Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
West Pharmaceutical Services
(NY:
WST
)
344.00
+16.53 (+5.05%)
Official Closing Price
Updated: 7:00 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about West Pharmaceutical Services
< Previous
1
2
3
4
5
6
7
8
9
Next >
Looking Into West Pharmaceutical Servs's Recent Short Interest
November 08, 2024
Via
Benzinga
Peering Into West Pharmaceutical Servs's Recent Short Interest
November 06, 2024
Via
Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
November 04, 2024
Analyzing WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s Dividend Potential.
Via
Chartmill
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
October 24, 2024
West Pharmaceutical Services reported Q3 adjusted EPS of $1.85, beating estimates, with $746.9 million in sales. Updated 2024 guidance reflects higher EPS and sales.
Via
Benzinga
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
October 24, 2024
Via
Benzinga
Earnings Outlook For West Pharmaceutical Servs
October 23, 2024
Via
Benzinga
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
October 14, 2024
Via
Benzinga
Exploring NYSE:WST's dividend characteristics.
September 16, 2024
Exploring WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s dividend characteristics.
Via
Chartmill
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
August 29, 2024
Via
Benzinga
Is NYSE:WST a Good Fit for Dividend Investing?
August 21, 2024
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a good dividend investing stock.
Via
Chartmill
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
August 16, 2024
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
July 31, 2024
Why the dividend investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST).
Via
Chartmill
Why NYSE:WST is a Top Pick for Dividend Investors.
July 05, 2024
Exploring WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s dividend characteristics.
Via
Chartmill
How Is The Market Feeling About West Pharmaceutical Servs?
July 02, 2024
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:WST.
June 14, 2024
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a good dividend investing stock.
Via
Chartmill
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),...
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 25, 2024
Via
Benzinga
Peering Into West Pharmaceutical Servs's Recent Short Interest
June 07, 2024
Via
Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
May 14, 2024
Via
Benzinga
WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
July 25, 2024
WST stock results show that West Pharmaceutical Servs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
WST stock results show that West Pharmaceutical Servs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Why the dividend investor may take a look at NYSE:WST.
April 12, 2024
Via
Chartmill
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
March 26, 2024
Via
Benzinga
Exploring NYSE:WST's dividend characteristics.
March 22, 2024
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) is a Top Pick for Dividend Investors.
Via
Chartmill
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Analyzing NYSE:WST's Dividend Potential.
March 01, 2024
Is WEST PHARMACEUTICAL SERVICES (NYSE:WST) a Good Fit for Dividend Investing?
Via
Chartmill
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
February 15, 2024
Via
Benzinga
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
February 15, 2024
US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small caps outperform. Tesla, Wells Fargo, and CBRE rally on positive news while Deer...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
February 15, 2024
West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth,...
Via
Benzinga
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 15, 2024
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.